Women who started MHT within ten years of their final menstrual period actually had a lower than expected risk of coronary heart disease, and those who started ten or more years after their final menstrual period displayed a slightly increased risk. Women using MHT between the ages of fifty and fifty-nine also had a 30 percent lower risk of dying versus those women given placebo.
